Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Titles
NEW
 Top 50 Non-Healthcare Titles
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Biopharmaceutical CMO Global Market Report 2025
Request Sample Buy Now
Global Biopharmaceutical CMO Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Biopharmaceutical CMO Global Market Report 2025

By Product (Biologics, Biosimilars), By Source (Mammalian, Non-Mammalian), By Service (Manufacturing, Fill And Finish Operations, Analytical And QC Studies, Packaging) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Biopharmaceutical CMO Market Overview

• Biopharmaceutical CMO market size has reached to $24.81 billion in 2024

• Expected to grow to $47.79 billion in 2029 at a compound annual growth rate (CAGR) of 14.3%

• Growth Driver: Robust Venture Capital Investments Fuel Biopharmaceutical Cmo Market Growth

• Market Trend: Biopharmaceutical CMO Market Embraces Iot Technology Advancements

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biopharmaceutical CMO Market?

Biopharmaceutical CMO is a business that provides manufacturing services, with the capacity to produce small quantities for preclinical research and development and more significant numbers needed for clinical trials and commercialization. The biopharmaceutical CMO assists in lowering overall operational risk and time to market.

The main types of biopharmaceutical CMO products includes biologics and biosimilars. The biologics are used to produce a wide range of products derived from human, animal, or microbial sources as biologic medications. Biologics are substance made from living things or contains some components of them. Vaccines, blood, blood components, cells, allergies, genes, tissues, and recombinant proteins are some of the biologic medications. The biopharmaceutical CMO products comes from various sources including mammalian and non-mammalian. The biopharmaceutical CMO services includes manufacturing, fill and finish operations, analytical and qc studies, and packaging.

Biopharmaceutical CMO Market Size and growth rate 2025 to 2029: Graph

What Is The Biopharmaceutical CMO Market Size 2025 And Growth Rate?

The biopharmaceutical CMO market size has grown rapidly in recent years. It will grow from $24.81 billion in 2024 to $28.02 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to increasing demand for biopharmaceuticals, globalization, rise in healthcare expenditure, regulatory support, increased research funding.

What Is The Biopharmaceutical CMO Market Growth Forecast?

The biopharmaceutical CMO market size is expected to see rapid growth in the next few years. It will grow to $47.79 billion in 2029 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to rise in telehealth and remote trials, global health initiatives, rise in disposable income, global health initiatives. Major trends in the forecast period include advanced therapies dominance, digitalization and industry 4.0, continuous manufacturing, sustainability and green practices.

The forecast of 14.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. drug production by driving up the cost of contract manufacturing services and purification columns sourced from India and Spain, exacerbating biologic drug shortages and increasing production costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Biopharmaceutical CMO Market Segmented?

1) By Product: Biologics, Biosimilars

2) By Source: Mammalian, Non-Mammalian

3) By Service: Manufacturing, Fill And Finish Operations, Analytical And QC Studies, Packaging

Subsegments:

1) By Biologics: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Cell and Gene Therapies

2) By Biosimilars: Biosimilar Monoclonal Antibodies, Biosimilar Recombinant Proteins, Biosimilar Insulins, Biosimilar Growth Hormones

What Is Driving The Biopharmaceutical CMO Market? Robust Venture Capital Investments Fuel Biopharmaceutical Cmo Market Growth

An increase in geriatric population is expected to propel the growth of the biopharmaceutical CMO market. People whose age is more than 60 years are more likely to suffer a heart attack, a stroke, or develop coronary heart disease and heart failure than younger people.The increase in the geriatric population is driven by advances in healthcare, declining birth rates, and the aging of the baby boomer generation. The increase in the geriatric population is driving demand for biopharmaceutical therapies targeting age-related diseases, such as cardiovascular disorders, with biopharmaceutical CMOs playing an important role by providing specialized manufacturing capabilities for complex biologics and personalized medicines tailored to address these needs. For instance, in January 2024, according to the Population Reference Bureau, a US-based non-profit organization, the number of Americans aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050. Therefore, an increase in geriatric population is driving the biopharmaceutical CMO industry growth.

What Is Driving The Biopharmaceutical CMO Market? Biopharmaceutical Cmo Market And Chronic Disease Burden

The increasing burden of chronic diseases is expected to propel the growth of the biopharmaceutical CMO market going forward. Chronic diseases are long-term health conditions that persist over a person's lifetime, often progressing slowly and requiring ongoing medical management. Biopharmaceutical CMOs can enhance the fight against chronic diseases by expediting drug development, ensuring cost-effective production, and maintaining high-quality standards, thereby increasing accessibility and affordability of life-saving medications. For instance, in 2022, according to National Library of Medicine, US Government journal on chronic diseases, the number of people in the United States aged 50 years and older will increase by 61.11% from 137.25 million in 2020 to 221.13 million in 2050. Of the population 50 years and older, the number with at least one chronic disease is estimated to increase by 99.5% from 71.522 million in 2020 to 142.66 million by 2050. Therefore, increasing burden of chronic diseases drives the biopharmaceutical CMOs industry.

Who Are The Major Players In The Global Biopharmaceutical CMO Market?

Major companies operating in the biopharmaceutical cmo market include Lonza Group AG, Fujifilm Diosynth Biotechnologies USA Inc., Thermo Fisher Scientific Inc., Samsung Biologics, WuXi AppTec, Catalent, Inc., Rentschler Biopharma SE, Boehringer Ingelheim, Recipharm AB, AGC Biologics, CMC Biologics, KBI Biopharma, Vetter Pharma International GmbH, Emergent BioSolutions Inc., Aenova Group, Synlogic, Inc., MedImmune (AstraZeneca), BioLife Sciences, Bio-Xcellence (Boehringer Ingelheim), AbbVie Contract Manufacturing, PCI Pharma Services, AltheaDx, Daxor Corporation, Genomatica, Inc., Astellas Pharma, Juno Therapeutics (Celgene), Medpace, Celerion, Evonik Industries AG

What Are The Key Trends Of The Global Biopharmaceutical CMO Market? Biopharmaceutical CMO Market Embraces IoT Technology Advancements

Technological advancement is a key trend gaining popularity in the biopharmaceutical CMO market. Major companies in the biopharmaceutical CMO market are advancing in their new technologies and research and development using Iot. The Internet of Things (IoT) refers to the application of networked sensors and actuators to regulate and observe the environment, the objects that move within it, and the people who act within it. A vast amount of data can be produced by sensors, actuators, and other components integrated into manufacturing machinery and networked computer systems. The data can be analyzed for insights and opportunities to increase production efficiency, automate monitoring and controlling tasks, and enable adaptable manufacturing systems. For instance, in February 2022, M2Cloud, a Korea-based bio-cold chain technology company, along with Thales, a France-based company specializing in IoT communication modules, developed an IoT-based LTE monitoring system for biopharmaceutical monitoring. It is helpful in the real-time monitoring of freezers, refrigerated warehouses, etc., along with tracking the delivery boxes being delivered in real-time. It can remotely verify temperature and position information in real time by just turning on the power. With technologies designed for biopharmaceutical management, it increases the safety of pharmaceutical products.

What Are The Key Trends Of The Global Biopharmaceutical CMO Market? Biopharmaceutical Cmo Market Consolidation Trends

Major companies operating in the biopharmaceutical CMO market are adopting strategic partnerships approach to develop innovative biopharmaceutical products. Strategic partnerships help biopharmaceutical CMO companies by combining resources and expertise, enhancing research and development capabilities, expanding market reach, and accelerating commercialization, ultimately driving innovation and growth in the biopharmaceutical CMO industry. For instance, in May 2024, BioConnection, a Netherlands-based contract manufacturing company, partnered with AGC Biologics, a US-based contract development and manufacturing company. With this partnership, they aim to deliver a streamlined, comprehensive solution for biopharmaceutical development and manufacturing, expediting timelines and simplifying processes for drug developers.

Need data on a specific region in this market?
Request Customisation

Biopharmaceutical CMO Market Merger And Acquisition: Swiss company Lonza acquires Synaffix to boost ADC offering

In May 2023, WACKER, a Germany-based chemical company, acquired ADL BioPharma for an undisclosed amount. The aim of the acquisition is to enhance WACKER biotechnology operations and increase fermentation capacities for sustainably produced food ingredients, supporting its future growth objectives. ADL BioPharma is a Spain-based contract manufacturing company that specializes in the development and production of premium fermentation products.

Regional Outlook For The Global Biopharmaceutical CMO Market

North America was the largest region in the biopharmaceutical CMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in this market report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Biopharmaceutical CMO Market?

The biopharmaceutical CMO market includes revenues earned by entities by process development. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Biopharmaceutical CMO Industry?

The biopharmaceutical cmo market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biopharmaceutical cmo industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Biopharmaceutical CMO Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $28.02 billion
Revenue Forecast In 2034 $47.79 billion
Growth Rate CAGR of 14.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product: Biologics, Biosimilars
2) By Source: Mammalian, Non-Mammalian
3) By Service: Manufacturing, Fill And Finish Operations, Analytical And QC Studies, Packaging Subsegments: 1) By Biologics: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Cell and Gene Therapies
2) By Biosimilars: Biosimilar Monoclonal Antibodies, Biosimilar Recombinant Proteins, Biosimilar Insulins, Biosimilar Growth Hormones
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Lonza Group AG, Fujifilm Diosynth Biotechnologies USA Inc., Thermo Fisher Scientific Inc., Samsung Biologics, WuXi AppTec, Catalent, Inc., Rentschler Biopharma SE, Boehringer Ingelheim, Recipharm AB, AGC Biologics, CMC Biologics, KBI Biopharma, Vetter Pharma International GmbH, Emergent BioSolutions Inc., Aenova Group, Synlogic, Inc., MedImmune (AstraZeneca), BioLife Sciences, Bio-Xcellence (Boehringer Ingelheim), AbbVie Contract Manufacturing, PCI Pharma Services, AltheaDx, Daxor Corporation, Genomatica, Inc., Astellas Pharma, Juno Therapeutics (Celgene), Medpace, Celerion, Evonik Industries AG
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Biopharmaceutical CMO Market Characteristics

3. Biopharmaceutical CMO Market Trends And Strategies

4. Biopharmaceutical CMO Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biopharmaceutical CMO Growth Analysis And Strategic Analysis Framework

5.1. Global Biopharmaceutical CMO PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Biopharmaceutical CMO Market Growth Rate Analysis

5.4. Global Biopharmaceutical CMO Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Biopharmaceutical CMO Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Biopharmaceutical CMO Total Addressable Market (TAM)

6. Biopharmaceutical CMO Market Segmentation

6.1. Global Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biologics

Biosimilars

6.2. Global Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mammalian

Non-Mammalian

6.3. Global Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Manufacturing

Fill And Finish Operations

Analytical And QC Studies

Packaging

6.4. Global Biopharmaceutical CMO Market, Sub-Segmentation Of Biologics, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monoclonal Antibodies

Recombinant Proteins

Vaccines

Cell and Gene Therapies

6.5. Global Biopharmaceutical CMO Market, Sub-Segmentation Of Biosimilars, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biosimilar Monoclonal Antibodies

Biosimilar Recombinant Proteins

Biosimilar Insulins

Biosimilar Growth Hormones

7. Biopharmaceutical CMO Market Regional And Country Analysis

7.1. Global Biopharmaceutical CMO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Biopharmaceutical CMO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biopharmaceutical CMO Market

8.1. Asia-Pacific Biopharmaceutical CMO Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biopharmaceutical CMO Market

9.1. China Biopharmaceutical CMO Market Overview

9.2. China Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biopharmaceutical CMO Market

10.1. India Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biopharmaceutical CMO Market

11.1. Japan Biopharmaceutical CMO Market Overview

11.2. Japan Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biopharmaceutical CMO Market

12.1. Australia Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biopharmaceutical CMO Market

13.1. Indonesia Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biopharmaceutical CMO Market

14.1. South Korea Biopharmaceutical CMO Market Overview

14.2. South Korea Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biopharmaceutical CMO Market

15.1. Western Europe Biopharmaceutical CMO Market Overview

15.2. Western Europe Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biopharmaceutical CMO Market

16.1. UK Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biopharmaceutical CMO Market

17.1. Germany Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biopharmaceutical CMO Market

18.1. France Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biopharmaceutical CMO Market

19.1. Italy Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biopharmaceutical CMO Market

20.1. Spain Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biopharmaceutical CMO Market

21.1. Eastern Europe Biopharmaceutical CMO Market Overview

21.2. Eastern Europe Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biopharmaceutical CMO Market

22.1. Russia Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biopharmaceutical CMO Market

23.1. North America Biopharmaceutical CMO Market Overview

23.2. North America Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biopharmaceutical CMO Market

24.1. USA Biopharmaceutical CMO Market Overview

24.2. USA Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biopharmaceutical CMO Market

25.1. Canada Biopharmaceutical CMO Market Overview

25.2. Canada Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biopharmaceutical CMO Market

26.1. South America Biopharmaceutical CMO Market Overview

26.2. South America Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biopharmaceutical CMO Market

27.1. Brazil Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biopharmaceutical CMO Market

28.1. Middle East Biopharmaceutical CMO Market Overview

28.2. Middle East Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biopharmaceutical CMO Market

29.1. Africa Biopharmaceutical CMO Market Overview

29.2. Africa Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biopharmaceutical CMO Market Competitive Landscape And Company Profiles

30.1. Biopharmaceutical CMO Market Competitive Landscape

30.2. Biopharmaceutical CMO Market Company Profiles

30.2.1. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Fujifilm Diosynth Biotechnologies USA Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Samsung Biologics Overview, Products and Services, Strategy and Financial Analysis

30.2.5. WuXi AppTec Overview, Products and Services, Strategy and Financial Analysis

31. Biopharmaceutical CMO Market Other Major And Innovative Companies

31.1. Catalent, Inc.

31.2. Rentschler Biopharma SE

31.3. Boehringer Ingelheim

31.4. Recipharm AB

31.5. AGC Biologics

31.6. CMC Biologics

31.7. KBI Biopharma

31.8. Vetter Pharma International GmbH

31.9. Emergent BioSolutions Inc.

31.10. Aenova Group

31.11. Synlogic, Inc.

31.12. MedImmune (AstraZeneca)

31.13. BioLife Sciences

31.14. Bio-Xcellence (Boehringer Ingelheim)

31.15. AbbVie Contract Manufacturing

32. Global Biopharmaceutical CMO Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biopharmaceutical CMO Market

34. Recent Developments In The Biopharmaceutical CMO Market

35. Biopharmaceutical CMO Market High Potential Countries, Segments and Strategies

35.1 Biopharmaceutical CMO Market In 2029 - Countries Offering Most New Opportunities

35.2 Biopharmaceutical CMO Market In 2029 - Segments Offering Most New Opportunities

35.3 Biopharmaceutical CMO Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Biopharmaceutical CMO Market, Sub-Segmentation Of Biologics, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Biopharmaceutical CMO Market, Sub-Segmentation Of Biosimilars, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Biopharmaceutical CMO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Biopharmaceutical CMO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Indonesia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: South Korea, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Western Europe, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: UK, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Germany, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: France, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Italy, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Spain, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Russia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: North America, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: USA, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Canada, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: South America, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Brazil, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Middle East, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Africa, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Lonza Group AG Financial Performance
  • Table 77: Fujifilm Diosynth Biotechnologies USA Inc. Financial Performance
  • Table 78: Thermo Fisher Scientific Inc. Financial Performance
  • Table 79: Samsung Biologics Financial Performance
  • Table 80: WuXi AppTec Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Biopharmaceutical CMO Market, Sub-Segmentation Of Biologics, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Biopharmaceutical CMO Market, Sub-Segmentation Of Biosimilars, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Biopharmaceutical CMO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Biopharmaceutical CMO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Indonesia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: South Korea, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Western Europe, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: UK, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Germany, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: France, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Italy, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Spain, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Russia, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: North America, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: USA, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Canada, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: South America, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Brazil, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Middle East, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Africa, Biopharmaceutical CMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Biopharmaceutical CMO Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Biopharmaceutical CMO Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Lonza Group AG Financial Performance
  • Figure 77: Fujifilm Diosynth Biotechnologies USA Inc. Financial Performance
  • Figure 78: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 79: Samsung Biologics Financial Performance
  • Figure 80: WuXi AppTec Financial Performance

Latest Market Developments in Ketamine Clinic Industry: Forecast 2025–2029

Read More About Latest Market Developments in Ketamine Clinic Industry: Forecast 2025–2029

Competitive and Market Trend Analysis of Lifestyle Diseases Apps Industry Through 2029

Read More About Competitive and Market Trend Analysis of Lifestyle Diseases Apps Industry Through 2029

Industry Trends Show Locum Tenens Staffing Market Set to Expand at 11.6% CAGR Until 2029

Read More About Industry Trends Show Locum Tenens Staffing Market Set to Expand at 11.6% CAGR Until 2029

In-Depth Lung Cancer Surgery Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Lung Cancer Surgery Market Report: Business Trends, Growth Factors, and Forecast to 2029

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Read More About Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Read More About Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Read More About Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Animal And Pet Food Global Market Report 2025 – By Type (Pet Food, Animal Food), By Distribution Channel (Supermarkets/Hypermarkets, Convenience Stores, E-Commerce, Other Distribution Channels), By Ingredients (Animal De...

View Report

Greenhouse, Nursery, And Flowers Global Market Report 2025 – By Type (Food Crops Grown Under Cover, Nursery And Floriculture Production), By Application (Agricultural Products, Ornamental Plant, Grow Plants, Consumer Goo...

View Report

Crop Production Global Market Report 2025 – By Type (Grain Farming, Oilseed Farming, Fruit And Nut Farming, Vegetable Farming, General Crop Farming, Greenhouse, Nursery, And Flowers), By Farming Process (Organic Farming,...

View Report

Organic Vegetable Farming Global Market Report 2025 – By Type (Pure Organic Farming, Integrated organic farming), By Method (Composting, Crop Rotation, Cutting, Mulching, Polyculture, Soil Management, Weed Management), B...

View Report

Organic Tea Global Market Report 2025 – By Type (Green Tea, Black Tea, White Tea, Oolong Tea, Herbal Tea, Other Types), By Form (Dried Leaf, Liquid, Powder, Other Forms), By Product (Paper Pouches, Cans, Cartons, Tea Bag...

View Report

Fertilizing Machinery Global Market Report 2025 – By Product Type (Fertilizer Dryers, Fertilizer Screening Machines, Fertilizer Crushers, Fertilizer Granulators, Fertilizer Mixers), By Disc Type (Single Disc Fertilizer S...

View Report

Nonresidential Green Buildings Global Market Report 2025 – By Product (Interior Products, Exterior Products), By Component (Roofing, Insulation, Framing, Exterior Siding, Interior Finishing, Other Components), By Applica...

View Report

Commercial Greenhouse Global Market Report 2025 – By Type (Glass Greenhouse, Plastic Greenhouse), By Equipment Type (Cooling Systems, Heating Systems, Other Equipment), By Crop Type (Fruits, Vegetables, Flowers & Ornamen...

View Report

Frequently Asked Questions

Biopharmaceutical CMO is a business that provides manufacturing services, with the capacity to produce small quantities for preclinical research and development and more significant numbers needed for clinical trials and commercialization. The biopharmaceutical CMO assists in lowering overall operational risk and time to market. For further insights on this market, request a sample here

The market major growth driver - Robust Venture Capital Investments Fuel Biopharmaceutical Cmo Market Growth. For further insights on this market, request a sample here

The biopharmaceutical cmo market size has grown rapidly in recent years. It will grow from $24.81 billion in 2024 to $28.02 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to increasing demand for biopharmaceuticals, globalization, rise in healthcare expenditure, regulatory support, increased research funding. The biopharmaceutical cmo market size is expected to see rapid growth in the next few years. It will grow to " $47.79 billion in 2029 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to rise in telehealth and remote trials, global health initiatives, rise in disposable income, global health initiatives. Major trends in the forecast period include advanced therapies dominance, digitalization and industry 4.0, continuous manufacturing, sustainability and green practices. For further insights on this market, request a sample here

The biopharmaceutical cmomarket covered in this report is segmented –
1) By Product: Biologics; Biosimilars
2) By Source: Mammalian; Non-Mammalian
3) By Service: Manufacturing; Fill And Finish Operations; Analytical And QC Studies; Packaging Subsegments:
1) By Biologics: Monoclonal Antibodies; Recombinant Proteins; Vaccines; Cell and Gene Therapies
2) By Biosimilars: Biosimilar Monoclonal Antibodies; Biosimilar Recombinant Proteins; Biosimilar Insulins; Biosimilar Growth Hormones For further insights on this market, request a sample here

North America was the largest region in the biopharmaceutical CMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical cmo market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the biopharmaceutical cmo market include Lonza Group AG, Fujifilm Diosynth Biotechnologies USA Inc., Thermo Fisher Scientific Inc., Samsung Biologics, WuXi AppTec, Catalent, Inc., Rentschler Biopharma SE, Boehringer Ingelheim, Recipharm AB, AGC Biologics, CMC Biologics, KBI Biopharma, Vetter Pharma International GmbH, Emergent BioSolutions Inc., Aenova Group, Synlogic, Inc., MedImmune (AstraZeneca), BioLife Sciences, Bio-Xcellence (Boehringer Ingelheim), AbbVie Contract Manufacturing, PCI Pharma Services, AltheaDx, Daxor Corporation, Genomatica, Inc., Astellas Pharma, Juno Therapeutics (Celgene), Medpace, Celerion, Evonik Industries AG . For further insights on this market, request a sample here.

Major trends in this market include Biopharmaceutical CMO Market Embraces Iot Technology Advancements. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Biopharmaceutical CMO Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top